Cargando…

A score to predict short-term risk of COPD exacerbations (SCOPEX)

BACKGROUND: There is no clinically useful score to predict chronic obstructive pulmonary disease (COPD) exacerbations. We aimed to derive this by analyzing data from three existing COPD clinical trials of budesonide/formoterol, formoterol, or placebo in patients with moderate-to-very-severe COPD and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Make, Barry J, Eriksson, Göran, Calverley, Peter M, Jenkins, Christine R, Postma, Dirkje S, Peterson, Stefan, Östlund, Ollie, Anzueto, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315304/ https://www.ncbi.nlm.nih.gov/pubmed/25670896 http://dx.doi.org/10.2147/COPD.S69589

Ejemplares similares

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations
por: Calverley, Peter M, et al.
Publicado: (2016)

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
por: Eriksson, Göran, et al.
Publicado: (2017)

Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease
por: Jenkins, Christine R., et al.
Publicado: (2015)

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
por: Calverley, Peter M, et al.
Publicado: (2016)

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
por: Calverley, Peter MA, et al.
Publicado: (2017)

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD
por: Calverley, Peter MA, et al.
Publicado: (2018)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR(®) trial
por: Wise, Robert A, et al.
Publicado: (2018)

Airways inflammation and treatment during acute exacerbations of COPD
por: Bathoorn, Erik, et al.
Publicado: (2008)

Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT
por: Putcha, Nirupama, et al.
Publicado: (2022)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

The need to further understand who gets hospitalized for a COPD exacerbation
por: Maselli, Diego J, et al.
Publicado: (2012)

Towards precision in defining COPD exacerbations
por: Jenkins, Christine R.
Publicado: (2021)

Comparison of two scores for short-term outcomes in patients with COPD exacerbation in the emergency department: the Ottawa COPD Risk Scale and the DECAF score
por: Unal, Ali, et al.
Publicado: (2023)

Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes
por: Anzueto, A, et al.
Publicado: (2009)

Community-Acquired Respiratory Complications in the Intensive Care Unit: Pneumonia and Acute Exacerbations of COPD
por: Restrepo, M. I., et al.
Publicado: (2010)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

The effects of neuromuscular exercise on medial knee joint load post-arthroscopic partial medial meniscectomy: ‘SCOPEX’ a randomised control trial protocol
por: Hall, Michelle, et al.
Publicado: (2012)

Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation
por: Bathoorn, Erik, et al.
Publicado: (2009)

The association of tidal EFL with exercise performance, exacerbations, and death in COPD
por: Aarli, Bernt Boegvald, et al.
Publicado: (2017)

Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps
por: Bateman, Eric D, et al.
Publicado: (2011)

Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trial
por: Dusser, Daniel, et al.
Publicado: (2016)

Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD
por: Wilson, Robert, et al.
Publicado: (2015)

Impact of statins and ACE inhibitors on mortality after COPD exacerbations
por: Mortensen, Eric M, et al.
Publicado: (2009)

Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study
por: Dal Negro, Roberto W., et al.
Publicado: (2017)

Chronic obstructive pulmonary disease and exacerbations: Patient insights from the global Hidden Depths of COPD survey
por: Barnes, Neil, et al.
Publicado: (2013)

Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population
por: Sethi, Sanjay, et al.
Publicado: (2022)

A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology
por: Wilson, Robert, et al.
Publicado: (2011)

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results
por: Wilson, Robert, et al.
Publicado: (2012)

Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD
por: Rennard, Stephen I, et al.
Publicado: (2011)

Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score
por: Echevarria, Carlos, et al.
Publicado: (2019)

A clinical in-hospital prognostic score for acute exacerbations of COPD
por: Roche, Nicolas, et al.
Publicado: (2014)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study
por: Fattahi, Fatemeh, et al.
Publicado: (2013)

Impact of anemia on short-term survival in severe COPD exacerbations: a cohort study
por: Ergan, Begum, et al.
Publicado: (2016)

Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis
por: Jabarkhil, Ajmal, et al.
Publicado: (2020)

Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial
por: Watz, Henrik, et al.
Publicado: (2018)

A clinical prediction model for hospitalized COPD exacerbations based on “treatable traits”
por: Yii, Anthony C A, et al.
Publicado: (2019)

The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial
por: Patel, Naimish R, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4tf1qspf5h18t73ui9cilqb8p4